Fny Investment Advisers, LLC Axogen, Inc. Call Options Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 Apr 09, 2020	SELL	$8.38 - $17.34 $41 - $86	-5 Closed	0 $0
Q4 2019 Jan 10, 2020	SELL	$11.18 - $18.6 $436 - $725	-39 Reduced 88.64%	5 $0
Q3 2019 Oct 25, 2019	BUY	$12.09 - $20.46 $60 - $102	5 Added 12.82%	44 $0
Q2 2019 Jul 24, 2019	SELL	$18.5 - $25.47 $1,128 - $1,553	-61 Reduced 61.0%	39 $0
Q1 2019 Apr 17, 2019	BUY	$14.62 - $22.13 $1,462 - $2,213	100 New	100 $2,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.